Relypsa (RLYP) Reports Q4 Loss of $0.80/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
Go back to Relypsa (RLYP) Reports Q4 Loss of $0.80/Share
March 11, 2015 4:10 PM EDT
REDWOOD CITY, Calif., March 11, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq: RLYP), a biopharmaceutical company, today reported financial results for the fourth quarter and year ended December 31, 2014.
Cash, cash equivalents and short-term investments totaled $135.8 million at December 31, 2014, compared to $94.8 million at December 31, 2013. Shares outstanding as of December 31, 2014 were 35.0 million. Cash, cash equivalents and short-term investments at December 31, 2014 on a pro forma basis to include the impact of the company's first quarter 2015 activity under its at-the-market offering and an underwritten offering was approximately $349.5 million.
Research and development expenses for the fourth quarter of 2014 were $16.6... More
March 11, 2015 4:10 PM EDT
REDWOOD CITY, Calif., March 11, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq: RLYP), a biopharmaceutical company, today reported financial results for the fourth quarter and year ended December 31, 2014.
Cash, cash equivalents and short-term investments totaled $135.8 million at December 31, 2014, compared to $94.8 million at December 31, 2013. Shares outstanding as of December 31, 2014 were 35.0 million. Cash, cash equivalents and short-term investments at December 31, 2014 on a pro forma basis to include the impact of the company's first quarter 2015 activity under its at-the-market offering and an underwritten offering was approximately $349.5 million.
Research and development expenses for the fourth quarter of 2014 were $16.6... More
